{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "The Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "randomized to 1:1:1 versus 1:1:2 as described in the PROPPR trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "Severely injured patients predicted to receive a massive transfusion admitted to 12 level I North American trauma centers"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized to 1:1:1 versus 1:1:2 as described in the PROPPR trial"
      },
      "Objective": {
        "score": 1,
        "evidence": "we hypothesized that patients receiving 1:1:1 ratio would have improved survival after emergency laparotomy"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "post-surgical survival at 24-hours and 30-days"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "randomized to 1:1:1 versus 1:1:2"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Of the 680 enrolled patients"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "346 underwent an emergency laparotomy"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "24-hour survival was 86.8% (151/174) for 1:1:1 and 83.1% (143/172) for 1:1:2 (p=0.29)"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 14,
    "max_score": 25
  },
  "model": "gpt-4o"
}